机译:早期进展作为边缘区淋巴瘤存活的预测因子:来自FIL-NF10研究的分析
Azienda Unita Sanit Locale Ist Ricovero &
Cura Ca Div Hematol Reggio Emilia Italy;
Univ Insubria Univ Hosp Osped Circolo &
Fdn Macchi Azienda Soci Div Hematol Varese Italy;
Fdn IRCCS Policlin San Matteo Div Hematol Viale Golgi 19 I-27100 Pavia Italy;
Univ Modena &
Reggio Emilia PhD Program Clin &
Expt Med Modena Italy;
Fdn Italiana Linfomi Modena Italy;
Univ Turin Div Hematol Dept Mol Biotechnol &
Hlth Sci Turin Italy;
Fdn IRCCS Policlin San Matteo Div Hematol Viale Golgi 19 I-27100 Pavia Italy;
Univ Insubria Univ Hosp Osped Circolo &
Fdn Macchi Azienda Soci Div Hematol Varese Italy;
Azienda Unita Sanit Locale Ist Ricovero &
Cura Ca Div Hematol Reggio Emilia Italy;
Osped Niguarda Ca Granda Niguarda Canc Ctr Dept Hematol Milan Italy;
Osped Oncol Armando Businco Div Hematol Cagliari Italy;
Azienda Osped Univ Parma Div Hematol Parma Italy;
Univ Verona Dept Med Sect Hematol Verona Italy;
Univ Estadual Campinas Ctr Hematol &
Hemotherapy Fac Med Dept Internal Med Campinas SP Brazil;
Azienda Osped Univ Senese Div Hematol Dept Oncol Siena Italy;
Natl Canc Inst Div Med Oncol A Aviano Italy;
Univ Turin Div Hematol Dept Mol Biotechnol &
Hlth Sci Turin Italy;
Azienda Unita Sanit Locale Ist Ricovero &
Cura Ca Div Hematol Reggio Emilia Italy;
Osped Niguarda Ca Granda Niguarda Canc Ctr Dept Hematol Milan Italy;
Azienda Osped Papardo Dept Hematol Messina Italy;
Univ Campus Biomed Unit Hematol Stem Cell Transplantat Transfus Med Rome Italy;
Univ Roma La Sapienza Dept Cellular Biotechnol &
Hematol Rome Italy;
AOU Citta Salute &
Sci Torino Div Hematol 2 Turin Italy;
Fdn IRCCS Policlin San Matteo Div Hematol Viale Golgi 19 I-27100 Pavia Italy;
Univ Pavia Dept Mol Med Pavia Italy;
Fdn Italiana Linfomi Modena Italy;
Fdn IRCCS Policlin San Matteo Div Hematol Viale Golgi 19 I-27100 Pavia Italy;
机译:早期进展作为边缘区淋巴瘤存活的预测因子:来自FIL-NF10研究的分析
机译:将利妥昔单抗添加至氯丁酸布丁可在结外边缘区带B细胞淋巴瘤患者的治疗中产生卓越的无事件生存率:IELSG-19随机研究的5年分析。
机译:加入Rituximab到氯镁蛋白在治疗骨髓边缘区B细胞淋巴瘤患者中产生优异的无事项生存率:5年的IELSG-19随机研究分析。
机译:CD180:血浆膜微粒蛋白质组学分析发现的新边缘区B细胞淋巴瘤生物标志物
机译:边缘区B细胞与边缘区巨噬细胞之间的串扰。
机译:晚期边缘区淋巴瘤患者的R–CVP II期研究和利妥昔单抗维持治疗:联合会提高淋巴瘤生存率(CISL)研究
机译:绝对外周单核细胞计数预测粘膜相关淋巴组织外部边缘区淋巴瘤的无进展存活